Is Early-Stage Melanoma Recurrence Predictable with Artificial Intelligence?
Researchers from Massachusetts General Hospital (MGH), Boston, USA, have developed a novel way of predicting which patients with melanoma are more likely to experience a recurrence with artificial intelligence.